lung cancer Archive — Page 7 of 16
-
November 29, 2018
Lung cancer survival signal
A receptor thought to be a cell growth inhibitor actually sends pro-survival signals in small cell lung cancer and is a candidate biomarker for poor prognosis. -
October 25, 2018
Combination therapy improves small-cell lung cancer survival
Patients with stage IV small-cell lung cancer lived longer when given the immunotherapy atezolizumab with chemotherapy, setting the stage for what could become the first new treatment approved in decades for this particularly aggressive form of lung cancer. -
September 27, 2018
Team’s potential lung cancer therapy lands award from SBIR
A potential cancer drug aimed at enhancing the effectiveness of ionizing radiation in lung cancer patients is a step closer to development with funding support from the Small Business Innovation Research (SBIR) program. -
August 16, 2018
A new target for lung cancer
Vanderbilt researchers have identified a new vulnerability in lung cancer — the transporter protein xCT — that may a therapeutic target for the disease. -
June 14, 2018
Lung cancer patients and advocates visit VUMC research labs
A group of young lung cancer patients and their family members recently toured research laboratories at Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center (VICC) to learn how investigators are working to find better therapies and possibly a cure for the disease. -
June 8, 2018
$8.1 million grant funds new center to research highly aggressive form of lung cancer
A five-year National Cancer Institute grant will fund an interdisciplinary research center for the study of small cell lung cancer, a highly aggressive, incurable form of the disease. -
May 29, 2018
New research finds lung cancer risk drops substantially within five years of quitting smoking
Just because you stopped smoking years ago doesn’t mean you’re out of the woods when it comes to developing lung cancer. That’s the “bad” news. The good news is your risk of lung cancer drops substantially within five years of quitting.